| Level of HER2 Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab C Gomez-Martin, JC Plaza, R Pazo-Cid, A Salud, F Pons, P Fonseca, ... Journal of Clinical Oncology 31 (35), 4445-4452, 2013 | 219 | 2013 |
| A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for … C Gravalos, A Salut, C García-Girón, R García-Carbonero, AI León, ... Clinical and Translational Oncology 14, 606-612, 2012 | 59 | 2012 |
| Genomic profiling of HER2‐Positive gastric cancer: PI3K/Akt/mTOR pathway as predictor of outcomes in HER2‐positive advanced gastric cancer treated with trastuzumab A Díaz‐Serrano, B Angulo, C Dominguez, R Pazo‐Cid, A Salud, ... The oncologist 23 (9), 1092-1102, 2018 | 56 | 2018 |
| MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer C Caramés, I Cristóbal, V Moreno, L Del Puerto, I Moreno, M Rodriguez, ... International journal of colorectal disease 30, 899-906, 2015 | 52 | 2015 |
| A phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes LG Estévez, N Batista, P Sánchez-Rovira, A Velasco, M Provencio, ... Clinical breast cancer 8 (2), 149-154, 2008 | 49 | 2008 |
| Gemcitabine and carboplatin for patients with advanced non-small cell lung cancer M Dómine, V Casado, LG Estévez, A León, JI Martin, M Castillo, G Rubio, ... Seminars in oncology 28, 4-9, 2001 | 37 | 2001 |
| Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer J Feliu, P Borrega, A León, L López-Gómez, M López, J Castro, ... Cancer chemotherapy and pharmacology 67, 215-221, 2011 | 34 | 2011 |
| MicroRNA-31 emerges as a predictive biomarker of pathological response and outcome in locally advanced rectal cancer C Caramés, I Cristobal, V Moreno, JP Marín, P González-Alonso, ... International journal of molecular sciences 17 (6), 878, 2016 | 31 | 2016 |
| Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic … P Llovet, J Sastre, JS Ortega, I Bando, M Ferrer, P García-Alfonso, ... Molecular diagnosis & therapy 19, 397-408, 2015 | 31 | 2015 |
| Cesarean Scar Ectopic Pregnancy—Case Series: Treatment Decision Algorithm and Success with Medical Treatment LS Morente, AIG León, MPE Reina, JRA Herrero, EG Mesa, JSJ López Medicina 57 (4), 362, 2021 | 27 | 2021 |
| Comparative in vitro activity of clarithromycin E Loza, J Martínez Beltrán, F Baquero, A Leon, R Canton, B Garijo, ... European Journal of Clinical Microbiology and Infectious Diseases 11, 856-866, 1992 | 26 | 1992 |
| Gemcitabine/vinorelbine in metastatic breast cancer patients previously treated with anthracyclines: results of a phase II trial F Lobo, JA Virizuela, FJ Dorta, J Florián, M Lomas, E Jiménez, P López, ... Clinical Breast Cancer 4 (1), 46-50, 2003 | 22 | 2003 |
| Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy in stage II and III breast cancer patients: preliminary results of a phase II and pharmacogenomic study LG Estévez, P Sánchez-Rovira, M Dómine, A León, I Calvo, A Jaén, ... Seminars in oncology 31, 31-36, 2004 | 17 | 2004 |
| Early phase II of docetaxel in second line of advanced non small cell lung cancer (NSCLC): preliminary results JL Garcia-Lopez, M Domine, P Garrido, A Leon, C Crespo, E Lastra, ... Proc Am Soc Clin Oncol 19, 537a, 2000 | 16 | 2000 |
| Clinical outcomes of FOLFIRINOX and gemcitabine–nab paclitaxel for metastatic pancreatic cancer in the real world setting F Franco, JC Camara, JI Martín-Valadés, A López-Alfonso, D Marrupe, ... Clinical and Translational Oncology 23, 812-819, 2021 | 15 | 2021 |
| VITAL phase 2 study: Upfront 5‐fluorouracil, mitomycin‐C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09‐02) J Feliu, R Garcia‐Carbonero, J Capdevila, I Guasch, V Alonso‐Orduna, ... Cancer Medicine 9 (3), 1008-1016, 2020 | 14 | 2020 |
| Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results … LG Estévez, P Sánchez-Rovira, M Dómine, A León, I Calvo, A Jaén, ... Clinical and Translational Oncology 9, 317-322, 2007 | 8 | 2007 |
| Diagnóstico de la GC en una empresa grande de pinturas de Barranquilla (Colombia) A León, JP Castro, M Roncallo Ingeniería y Desarrollo 16, 70-103, 2004 | 8 | 2004 |
| A phase II trial of a two hour infusion of gemcitabine with carboplatin for advanced non small cell lung cancer (NSCLC) M Domine, L Estevez, A Leon, V Casado, I Martin, M Castillo, G Rubio, ... Proc Am Soc Clin Oncol 21, 225b, 2002 | 8 | 2002 |
| Phase II trial of gemcitabine (GEM) and 48-h continuous infusion (CI) of 5-fluorouracil (5-FU) as first-line treatment for patients with locally advanced and metastatic … J Maurel, JL Garcıa López, A Léon, J Bréton, C Fernandez Martos, ... Proc Am Soc Clin Oncol 20, A2290, 2001 | 7 | 2001 |
